With every passing day, new discoveries are made that lend support to the increasing and important role biomarker analysis and tumor profiling play in personalized cancer care. Caris Life Sciences® is actively participating in research to advance the understanding of molecular science, further enabling the delivery of precision medicine.

Microsatellite instability status determined by next-generation sequencing and compared with PD-L1 and tumor mutational burden in 11,348 patients

Molecular profiles of small cell bladder and prostate cancer, comparisons with small cell lung cancer

A Phase II Trial of Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN BLADDER)

Validation of a Microsatellite Instability Assay by NGS

Molecular Characterization of Intestinal and Diffuse Types of Gastric Cancer

Differences in Molecular Profiles of Males and Females with Colorectal Cancer (CRC)

Composition of the immune microenvironment differs between carcinomas

Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas

ASH 2017-ADAPT-Aptamer C10.36 Reveals a Ribonucleoprotein Complex on the Surface of Non-Hodgkin Lymphoma Cells Providing Candidates for Multi-Target Therapeutics

Polyligand profiling differentiates breast cancer patients according to their benefit from trastuzumab treatment